KEGG   DRUG: Crotedumab
Entry
D11230                      Drug                                   
Name
Crotedumab (USAN/INN)
Formula
C6518H10044N1732O2052S46
Exact mass
146884.1989
Mol weight
146974.94
Sequence
(Heavy chain)
EVQLVESGGG LVQPGGSLRL SCAASGFTFS NYLMNWVRQA PGKGLEWLAN IQEDGIEKYY
VDSVKGRFTI SRDNAKNSLY LQMNSLRAED TAVYYCAREP SHYDILTGYD YYYGMDVWGQ
GTTVTVSSAS TKGPSVFPLA PCSRSTSEST AALGCLVKDY FPEPVTVSNN SGALTSGVHT
FPAVLQSSGL YSLSSVVTVP SSSLGTKTYT CNVDHKPSNT KVDKRVESKY GPPCPPCPAP
EFLGGPSVFL FPPKPKDTLM ISRTPEVTCV VVDVSQEDPE VQFNWYVDGV EVHNAKTKPR
EEQFNSTYRV VSVLTVLHQD WLNGKEYKCK VSNKGLPSSI EKTISKAKGQ PREPQVYTLP
PSQEEMTKNQ VSLTCLVKGF YPSDIAVEWE SNGQPENNYK TTPPVLDSDG SFFLYSRLTV
DKSRWQEGNV FSCSVMHEAL HNHYTQKSLS LSLGK
(Light chain)
DIQMTQSPSS LSASVGDRVT ITCRASQGIR NDLGWYQQKP GKAPKRLIYA ASSLQSGVPS
RFSGSGSGTE FILTVSSLQP EDFATYYCLQ YNENPFTFGP GTKVDIKRTV AAPSVFIFPP
SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
LSKADYEEHK VYACEVTHQG LSSPVTKSFN RGEC
(Disulfide bridge: H22-H96, H142-L214, H155-H211, H234-H'234, H237-H'237, H269-H329, H375-H433, H'22-H'96, H'142-L'214, H'155-H'211, H'269-H'329, H'375-H'433, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  Type
Peptide
Efficacy
Antidiabetic
  Type
Monoclonal antibody
Comment
Treatment of diabetes
Target
GCGR [HSA:2642] [KO:K04583]
  Pathway
hsa04080  Neuroactive ligand-receptor interaction
hsa04922  Glucagon signaling pathway
Brite
Target-based classification of drugs [BR:br08310]
 G Protein-coupled receptors
  Secretin receptor family
   Glucagon
    GCGR
     D11230  Crotedumab (USAN/INN)
Other DBs
CAS: 1452387-69-7
PubChem: 384585208

» Japanese version   » Back

DBGET integrated database retrieval system